MIBG Therapy for Pheochromocytomas and Paragangliomas
2 Views
administrator
07/02/23
Dr. David Mankoff discusses meta-Iodobenzylguanidine (MIBG) therapy, which is a highly targeted therapy for treatment of pheochromocytomas and paragangliomas, at the 2012 Focus on Neuroendocrine Tumors Conference.
-
Category
Show more
Facebook Comments
No comments found